BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 35125829)

  • 1. Celiac disease: From genetics to epigenetics.
    Gnodi E; Meneveri R; Barisani D
    World J Gastroenterol; 2022 Jan; 28(4):449-463. PubMed ID: 35125829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA class II genes in precision-based care of childhood diseases: what we can learn from celiac disease.
    Del Pozzo G; Farina F; Picascia S; Laezza M; Vitale S; Gianfrani C
    Pediatr Res; 2021 Jan; 89(2):307-312. PubMed ID: 33122841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Phospholipid Profile at 4 Months Predicts the Onset of Celiac Disease in at-Risk Infants.
    Auricchio R; Galatola M; Cielo D; Amoresano A; Caterino M; De Vita E; Illiano A; Troncone R; Greco L; Ruoppolo M
    Sci Rep; 2019 Oct; 9(1):14303. PubMed ID: 31586100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-factors, Microbes, and Immunogenetics in Celiac Disease to Guide Novel Approaches for Diagnosis and Treatment.
    Verdu EF; Schuppan D
    Gastroenterology; 2021 Nov; 161(5):1395-1411.e4. PubMed ID: 34416277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Celiac disease risk stratification based on HLA-DQ heterodimer (HLA-DQA1 ~ DQB1) typing in a large cohort of adults with suspected celiac disease.
    Choung RS; Mills JR; Snyder MR; Murray JA; Gandhi MJ
    Hum Immunol; 2020; 81(2-3):59-64. PubMed ID: 32005535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA-DQ: Celiac disease
    Bosca-Watts MM; Minguez M; Planelles D; Navarro S; Rodriguez A; Santiago J; Tosca J; Mora F
    World J Gastroenterol; 2018 Jan; 24(1):96-103. PubMed ID: 29358886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Celiac disease susceptibility: The genome and beyond.
    García-Santisteban I; Romero-Garmendia I; Cilleros-Portet A; Bilbao JR; Fernandez-Jimenez N
    Int Rev Cell Mol Biol; 2021; 358():1-45. PubMed ID: 33707051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gluten Degrading Enzymes for Treatment of Celiac Disease.
    Wei G; Helmerhorst EJ; Darwish G; Blumenkranz G; Schuppan D
    Nutrients; 2020 Jul; 12(7):. PubMed ID: 32679754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-Host Factors Influencing Onset and Severity of Celiac Disease.
    Galipeau HJ; Hinterleitner R; Leonard MM; Caminero A
    Gastroenterology; 2024 Jun; 167(1):34-50. PubMed ID: 38286392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elucidating the role of microbes in celiac disease through gnotobiotic modeling.
    Caminero A; Verdu EF; Galipeau HJ
    Methods Cell Biol; 2023; 179():77-101. PubMed ID: 37625882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Celiac disease: how complicated can it get?
    Tjon JM; van Bergen J; Koning F
    Immunogenetics; 2010 Oct; 62(10):641-51. PubMed ID: 20661732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-localization of gluten consumption and HLA-DQ2 and -DQ8 genotypes, a clue to the history of celiac disease.
    Lionetti E; Catassi C
    Dig Liver Dis; 2014 Dec; 46(12):1057-63. PubMed ID: 25200477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex bias in celiac disease: XWAS and monocyte eQTLs in women identify TMEM187 as a functional candidate gene.
    Hernangomez-Laderas A; Cilleros-Portet A; Martínez Velasco S; Marí S; Legarda M; González-García BP; Tutau C; García-Santisteban I; Irastorza I; Fernandez-Jimenez N; Bilbao JR
    Biol Sex Differ; 2023 Dec; 14(1):86. PubMed ID: 38072919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On the immune response to barley in celiac disease: Biased and public T-cell receptor usage to a barley unique and immunodominant gluten epitope.
    Dahal-Koirala S; Neumann RS; Jahnsen J; Lundin KEA; Sollid LM
    Eur J Immunol; 2020 Feb; 50(2):256-269. PubMed ID: 31628754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contrasting the Genetic Background of Type 1 Diabetes and Celiac Disease Autoimmunity.
    Gutierrez-Achury J; Romanos J; Bakker SF; Kumar V; de Haas EC; Trynka G; Ricaño-Ponce I; Steck A; ; Chen WM; Onengut-Gumuscu S; Simsek S; ; Rewers M; Mulder CJ; Liu E; Rich SS; Wijmenga C
    Diabetes Care; 2015 Oct; 38 Suppl 2(Suppl 2):S37-44. PubMed ID: 26405070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA class II alleles in Norwegian patients with coexisting type 1 diabetes and celiac disease.
    Viken MK; Flåm ST; Skrivarhaug T; Amundsen SS; Sollid LM; Drivvoll AK; Joner G; Dahl-Jørgensen K; Lie BA
    HLA; 2017 May; 89(5):278-284. PubMed ID: 28247576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A fast, cheap, and easy protocol for celiac disease HLA haplotype typing using buccal swabs.
    Sebastian-delaCruz M; Castellanos-Rubio A
    Methods Cell Biol; 2023; 179():203-212. PubMed ID: 37625876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Celiac disease: from pathogenesis to novel therapies.
    Schuppan D; Junker Y; Barisani D
    Gastroenterology; 2009 Dec; 137(6):1912-33. PubMed ID: 19766641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA-DQ2.5 genes associated with celiac disease risk are preferentially expressed with respect to non-predisposing HLA genes: Implication for anti-gluten T cell response.
    Pisapia L; Camarca A; Picascia S; Bassi V; Barba P; Del Pozzo G; Gianfrani C
    J Autoimmun; 2016 Jun; 70():63-72. PubMed ID: 27083396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding Celiac Disease by Genomics.
    Withoff S; Li Y; Jonkers I; Wijmenga C
    Trends Genet; 2016 May; 32(5):295-308. PubMed ID: 26972670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.